Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Glaukos enrols first subject in Phase II dry eye disease drug trial,

Glaukos has announced the first subject enrolment in the Phase II clinical trial of its investigational drug candidate GLK-301 to treat dry eye …, Glaukos has announced the first subject enrolment in the Phase II clinical trial of its investigational drug candidate GLK-301 to treat dry eye …, Read More

Scroll to Top